Legend Biotech Corporation
LEGN
$34.86
$1.374.09%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -76.21% | 22.36% | 68.35% | -24.14% | -483.88% |
| Total Depreciation and Amortization | 30.35% | 103.57% | 0.43% | 14.78% | -20.34% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -23.48% | 145.16% | -89.16% | 114.29% | 192.56% |
| Change in Net Operating Assets | -141.93% | -165.93% | 232.63% | 51.90% | -71.59% |
| Cash from Operations | -597.26% | -142.38% | 320.83% | 87.41% | -26.27% |
| Capital Expenditure | 39.36% | -147.13% | 45.74% | -361.20% | 15.72% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -124.66% | 4,440.19% | 90.41% | -160.44% | 402.37% |
| Cash from Investing | -126.31% | 3,292.27% | 87.92% | -164.51% | 391.93% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -35.70% | -59.14% | 52.34% | -57.88% | 12.85% |
| Issuance of Common Stock | -67.85% | -75.55% | 365.93% | -80.50% | 138.50% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -85.47% | -196.57% | 167.68% | -265.00% | 281.27% |
| Foreign Exchange rate Adjustments | 53.45% | -190.87% | -36.12% | 217.21% | 161.14% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -141.01% | 4,962.61% | 107.03% | -212.98% | 189.82% |